Hatt M, Krizsan AK, Rahmim A, Bradshaw TJ, Costa PF, Forgacs A, et al. Joint EANM/SNMMI guideline on radiomics in nuclear medicine. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-06001-6.

Article  PubMed  PubMed Central  Google Scholar 

Rogers W, Thulasi Seetha S, Refaee TAG, Lieverse RIY, Granzier RWY, Ibrahim A, et al. Radiomics: from qualitative to quantitative imaging. Br J Radiol. 2020;93:20190948.

Article  PubMed  PubMed Central  Google Scholar 

Orlhac F, Soussan M, Chouahnia K, Martinod E, Buvat I. 18F-FDG PET-derived textural indices reflect tissue-specific uptake pattern in non-small cell lung cancer. PLoS ONE. 2015;10:1–16.

Article  Google Scholar 

Pfaehler E, Mesotten L, Zhovannik I, Pieplenbosch S, Thomeer M, Vanhove K, et al. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer. Med Phys. 2021;48:1226–38.

Article  PubMed  Google Scholar 

Liberini V, de Santi B, Rampado O, Gallio E, Dionisi B, Ceci F, et al. Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor. EJNMMI Phys. 2021;8:1–21.

Article  Google Scholar 

Weber M, Kessler L, Schaarschmidt B, Fendler WP, Lahner H, Antoch G, et al. Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors. Nucl Med Commun. 2020;41:363–9.

Article  CAS  PubMed  Google Scholar 

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, et al. Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy. Mol Imaging Biol. 2019;21:582–90.

Article  CAS  PubMed  Google Scholar 

Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJR. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging. 2013;40:133–40.

Article  PubMed  Google Scholar 

Xu H, Abdallah N, Marion JM, Chauvet P, Tauber C, Carlier T, et al. Radiomics prognostic analysis of PET/CT images in a multicenter head and neck cancer cohort: investigating ComBat strategies, sub-volume characterization, and automatic segmentation. Eur J Nucl Med Mol Imaging. 2023;50:1720–34.

Article  PubMed  Google Scholar 

Hatt M, Majdoub M, Vallières M, Tixier F, Le Rest CC, Groheux D, et al. 18F-FDG PET uptake characterization through texture analysis: Investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med. 2015;56:38–44.

Article  CAS  PubMed  Google Scholar 

Lapa C, Werner RA, Schmid JS, Papp L, Zsótér N, Biko J, et al. Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy. Nucl Med Biol. 2015;42:349–54. https://doi.org/10.1016/j.nucmedbio.2014.12.006.

Article  CAS  PubMed  Google Scholar 

Shahzadi I, Zwanenburg A, Lattermann A, Linge A, Baldus C, Peeken JC, et al. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Sci Rep. 2022;12:1–15. https://doi.org/10.1038/s41598-022-13967-8.

Article  CAS  Google Scholar 

Welch ML, McIntosh C, Haibe-Kains B, Milosevic MF, Wee L, Dekker A, et al. Vulnerabilities of radiomic signature development: the need for safeguards. Radiother Oncol. 2019;130:2–9. https://doi.org/10.1016/j.radonc.2018.10.027.

Article  PubMed  Google Scholar 

De Schepper S, Gnanasegaran G, Dickson JC, Van den Wyngaert T. Absolute quantification in diagnostic spect/ct: the phantom premise. Diagnostics. 2021;11:1–15.

Article  Google Scholar 

Forgacs A, Pall Jonsson H, Dahlbom M, Daver F, Difranco MD, Opposits G, et al. A study on the basic criteria for selecting heterogeneity parameters of F18-FDG PET images. PLoS ONE. 2016;11:1–14.

Article  Google Scholar 

Dickson J, Ross J, Vöö S. Quantitative SPECT: the time is now. EJNMMI Phys. 2019;6:1–7.

Article  Google Scholar 

Ljungberg M. Absolute quantitation of SPECT studies. Semin Nucl Med. 2018;48:348–58. https://doi.org/10.1053/j.semnuclmed.2018.02.009.

Article  PubMed  Google Scholar 

Alipour R, Jackson P, Bressel M, Hogg A, Callahan J, Hicks RJ, et al. The relationship between tumour dosimetry, response, and overall survival in patients with unresectable neuroendocrine neoplasms (NEN) treated with 177Lu DOTATATE (LuTate). Eur J Nucl Med Mol Imaging. 2023;50:2997–3010. https://doi.org/10.1007/s00259-023-06257-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wetz C, Genseke P, Apostolova I, Furth C, Ghazzawi S, Rogasch JMM, et al. The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE. PLoS ONE. 2019;14:1–14.

Article  Google Scholar 

Pathmanandavel S, Crumbaker M, Ho B, Yam AO, Wilson P, Niman R, et al. Evaluation of 177Lu-PSMA-617 SPECT/CT quantitation as a response biomarker within a prospective 177Lu-PSMA-617 and NOX66 combination trial (LuPIN). J Nucl Med. 2023;64:221–6.

Article  PubMed  PubMed Central  Google Scholar 

Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging. 2017;1:1–16.

Article  Google Scholar 

Collarino A, Pereira Arias-Bouda LM, Valdés Olmos RA, van der Tol P, Dibbets-Schneider P, de Geus-Oei LF, et al. Experimental validation of absolute SPECT/CT quantification for response monitoring in breast cancer. Med Phys. 2018;45:2143–53.

Article  CAS  PubMed  Google Scholar 

Piwowarska-Bilska H, Kurkowska S, Birkenfeld B. Optimized method for normal range estimation of standardized uptake values (SUVmax, SUVmean) in liver SPECT/CT images with somatostatin analog [99mTc]-HYNIC-TOC (Tektrotyd). Nucl Med Rev. 2022;25:37–46.

Article  Google Scholar 

Data Spectrum Corporation, Greer K. NEMA IEC Body Phantom set: User’s Manual. 2008.

Nioche C, Orlhac F, Boughdad S, Reuze S, Goya-Outi J, Robert C, et al. Lifex: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–9.

Article  CAS  PubMed  Google Scholar 

Orlhac F, Nioche C, Klyuzhin I, Rahmim A, Buvat I. Radiomics in PET imaging: a practical guide for newcomers. PET Clin. 2021;16:597–612.

Article  PubMed  Google Scholar 

Hatt M, Tixier F, Pierce L, Kinahan PE, Le Rest CC, Visvikis D. Characterization of PET/CT images using texture analysis: the past, the present… any future? Eur J Nucl Med Mol Imaging. 2017;44:151–65. https://doi.org/10.1007/s00259-016-3427-0.

Article  PubMed  Google Scholar 

Pfaehler E, Van Sluis J, Merema BBJ, Van Ooijen P, Berendsen RCM, Van Velden FHP, et al. Experimental multicenter and multivendor evaluation of the performance of PET radiomic features using 3-dimensionally printed phantom inserts. J Nucl Med. 2020;61:469–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328–38.

Article  PubMed  Google Scholar 

Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, et al. SUV of [68Ga]DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors. Mol Imaging Biol. 2015;17:313–8.

Article  CAS  PubMed  Google Scholar 

Wetz C, Apostolova I, Steffen IG, Hofheinz F, Furth C, Kupitz D, et al. Predictive value of asphericity in pretherapeutic [111In]DTPA-octreotide SPECT/CT for response to peptide receptor radionuclide therapy with [177Lu]DOTATATE. Mol Imaging Biol. 2017;19:437–45. https://doi.org/10.1007/s11307-016-1018-x.

Article  CAS  PubMed  Google Scholar 

Dickson JC, Armstrong IS, Gabiña PM, Denis-Bacelar AM, Krizsan AK, Gear JM, et al. EANM practice guideline for quantitative SPECT-CT. Eur J Nucl Med Mol Imaging. 2023;50:980–95. https://doi.org/10.1007/s00259-022-06028-9.

Article  PubMed  Google Scholar 

Kaalep A, Burggraaff CN, Pieplenbosch S, Verwer EE, Sera T, Zijlstra J, et al. Quantitative implications of the updated EARL 2019 PET–CT performance standards. EJNMMI Phys. 2019;6:1–16.

Article